ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases
V Kočka, L Lisa, P Toušek, T Buděšínský… - European heart …, 2013 - academic.oup.com
Bioresorbable vascular scaffolds (BVS) have the potential to start new era in interventional
cardiology. First clinical studies in stable coronary artery disease have demonstrated a good …
cardiology. First clinical studies in stable coronary artery disease have demonstrated a good …
[HTML][HTML] Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the …
S Brugaletta, T Gori, P Tousek… - …, 2020 - eurointervention.pcronline.com
Aims: The aim of this study was to compare five-year clinical outcomes between an
everolimus-eluting bioresorbable scaffold (BRS) and an everolimus-eluting metallic stent …
everolimus-eluting bioresorbable scaffold (BRS) and an everolimus-eluting metallic stent …
Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction
Aims: Limited data are currently available on midterm outcomes after implantation of
everolimus-eluting bioresorbable vascular scaffolds (BVS) for treatment of acute ST …
everolimus-eluting bioresorbable vascular scaffolds (BVS) for treatment of acute ST …
A prospective evaluation of a pre-specified absorb BVS implantation strategy in ST-segment elevation myocardial infarction: the BVS STEMI STRATEGY-IT study
A Ielasi, G Campo, C Rapetto, A Varricchio… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of this study was to assess the feasibility and clinical results following a
pre-specified bioresorbable scaffold (Absorb BVS) implantation strategy in patients with ST …
pre-specified bioresorbable scaffold (Absorb BVS) implantation strategy in patients with ST …
[HTML][HTML] Are BVS suitable for ACS patients? Support from a large single center real live registry
Objectives To investigate one-year outcomes after implantation of a bioresorbable vascular
scaffold (BVS) in patients presenting with acute coronary syndrome (ACS) compared to …
scaffold (BVS) in patients presenting with acute coronary syndrome (ACS) compared to …
[PDF][PDF] ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year …
S Brugaletta, T Gori, AF Low… - International …, 2016 - scholarbank.nus.edu.sg
ST-segment elevation myocardial infarction (STEMI) represents a challenging and
appealing clinical scenario for the physiological advantages of bioresorbable vascular …
appealing clinical scenario for the physiological advantages of bioresorbable vascular …
Clinical comparison with short-term follow-up of bioresorbable vascular scaffold versus everolimus-eluting stent in primary percutaneous coronary interventions
B Cortese, A Ielasi, E Romagnoli, A Varricchio… - The American journal of …, 2015 - Elsevier
Objective of this study was to assess the clinical performance of bioresorbable vascular
scaffold (BVS) compared to everolimus-eluting stent (EES) in subjects with ST-segment …
scaffold (BVS) compared to everolimus-eluting stent (EES) in subjects with ST-segment …
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score …
S Brugaletta, T Gori, AF Low, P Tousek, E Pinar… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: The purpose of this study was to compare the 1-year outcome between
bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST …
bioresorbable vascular scaffold (BVS) and everolimus-eluting metallic stent (EES) in ST …
[PDF][PDF] Use of bioresorbable vascular scaffolds in patients with stable angina and acute coronary syndromes. Polish National Registry
Ł Rzeszutko, Z Siudak, A Włodarczak… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Background: Current revascularisation guidelines recommend coronary stenting with either
a bare metal stent or a drug eluting stent. The results of bioresorbable vascular scaffold …
a bare metal stent or a drug eluting stent. The results of bioresorbable vascular scaffold …
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience
E Moscarella, A Varricchio, E Stabile, A Latib… - International Journal of …, 2015 - Elsevier
This multicenter experience sought to investigate the feasibility and safety of BVS for the
treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) …
treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) …